Fora Capital, LLC Esperion Therapeutics, Inc. Transaction History

Fora Capital, LLC

  • $789 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$31.18 - $52.71 $182,558 - $308,617
-5,855 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$30.04 - $51.31 $15,500 - $26,475
516 Added 9.66%
5,855 $300 Million
Q1 2020

May 15, 2020
BUY
$27.44 - $73.84 $146,502 - $394,231
5,339 New
5,339 $168,000

Others Institutions Holding ESPR

# of Institutions
207
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $168M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email